Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Transgenic Organisms00:53

Transgenic Organisms

Overview
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Transgenic Plants02:50

Transgenic Plants

Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The elongated ciliated cells derived from nasal polyps are distinctly different from ciliated cells in different parts of the nasal mucosa.

Rhinology·2026
Same author

Intrinsically chiral exciton polaritons in an atomically-thin semiconductor.

Nature communications·2026
Same author

Average and Heterogeneous Associations between Secondhand Smoking and Tooth Loss.

Journal of dental research·2026
Same author

[Evaluation of the embryonic developmental toxicity of 3, 4-dinitrofurazanfuroxan using embryonic stem cell test model].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2026
Same author

[Subacute toxicity study of triethylenediammonium perchlorate ammonium complex salt in rats].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2025
Same author

[Surveillance of the population density of adult <i>Aedes albopictus</i> in Guangdong Province from 2018 to 2023].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2025
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Genetic adjuvants.

H C Ertl1, S Pasquini, Z He

  • 1The Wistar Institute, Philadelphia, PA.

Methods in Molecular Medicine
|March 5, 2011
PubMed
Summary
This summary is machine-generated.

The advent of DNA vaccines in 1992 enabled antibody production and immune responses. Various inoculation methods, including gene guns and intramuscular injections, are effective for DNA vaccine delivery.

More Related Videos

Live Cell Imaging of the TGF- &beta;/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Live Cell Imaging of the TGF- &beta;/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • The field of DNA vaccines emerged in 1992, marked by the demonstration of antibody production using plasmid vectors encoding foreign antigens.
  • Subsequent research rapidly confirmed the ability of DNA vaccines to stimulate robust immune responses, including cytotoxic T lymphocytes.
  • These responses were observed against a diverse range of antigens from pathogens and tumors.

Purpose of the Study:

  • To summarize the foundational discoveries and early developments in DNA vaccine technology.
  • To highlight the breadth of immune responses elicited by DNA vaccines.
  • To outline the various routes and methods employed for DNA vaccine administration.

Main Methods:

  • Plasmid vectors encoding specific antigens were utilized for inoculation.
  • Delivery methods included intradermal, intramuscular, subcutaneous, intravenous, and mucosal administration.
  • Common techniques involved gene gun delivery of DNA-coated gold beads and intramuscular injection of DNA in saline.

Main Results:

  • Successful induction of antibody production was demonstrated.
  • Stimulation of cell-mediated immunity, including cytotoxic T cells, was achieved.
  • Efficacy was shown against viral, bacterial, protozoal, and tumor-associated antigens.

Conclusions:

  • DNA vaccines represent a significant advancement in vaccinology, capable of inducing both humoral and cellular immunity.
  • The versatility in delivery routes and methods offers flexibility in vaccine application.
  • Early findings established DNA vaccines as a promising platform for infectious disease and cancer immunotherapy.